NEW YORK (GenomeWeb) — Maverix Biomics and Diagnomics announced today that they have received CLIA validation for their next-generation sequencing pre-natal test on the Maverix Dx platform.

The test, called Non-Invasive Chromosome Examination (NICE), was developed by Diagnomics and the Eone-Diagnomics Genome Center, a joint venture between Diagnomics and the Eone Life Science Institute. It uses NGS to detect fetal chromosome aneuploidies in cell-free DNA, the companies said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.